News
Hosted on MSN18d
PAVmed outlines strategic milestones for 2025, including Veris implantable device submissionVeris Health secured $2.4 million in private placement financing at a $35 million pre-money valuation and additional funding through a $1.8 million NIH grant. The company is progressing towards ...
Meximodo started in Metuchen, where it won a world record for most agave spirits in a single location. In late spring, it comes to Jersey City.
To receive daily news and insights, subscribe to our free daily Multifamily Dive newsletter. Veris Residential has identified a pipeline of $300 million to $500 million of assets, comprising the ...
Veris Health Inc. is a digital health company whose lead product, the Veris Cancer Care Platform, is a comprehensive digital care platform with remote physiological data collection, symptom ...
PAVmed Inc (PAVM) reports significant growth in test volumes and revenue, while securing strategic partnerships and funding to bolster future operations.
View Our Latest Analysis on VRE Veris Residential Price Performance Shares of VRE stock opened at $16.89 on Friday. The company has a debt-to-equity ratio of 1.34, a quick ratio of 0.73 and a ...
As you know PAVmed, as the parent company, has subsidiaries, including Lucid Diagnostics and Veris Health and last year’s spinout incubator PMX. As our subsidiaries succeed, particularly Lucid ...
Arrowstreet Capital Limited Partnership trimmed its holdings in Veris Residential, Inc. (NYSE:VRE – Free Report) by 16.4% in the 4th quarter, according to its most recent filing with the SEC. The ...
JERSEY CITY, N.J. (AP) — JERSEY CITY, N.J. (AP) — Veris Residential, Inc. (VRE) on Monday reported a key measure of profitability in its fourth quarter. The results missed Wall Street ...
Gross proceeds of approximately $2.4 million from sale of PAVmed securities priced at-the-market and Veris common stock priced at a $35 million pre-money valuation PAVmed Inc. is a diversified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results